Organicell Welcomes Harry Leider, MD, MBA as its New CEO

FORT LAUDERDALE, FL / ACCESSWIRE / June 21, 2023 / Organicell Regenerative Medicine, Inc. (OTCQB:OCEL), a clinical-stage biopharmaceutical company focused on the development of innovative biological regenerative therapeutics, is pleased to announce the appointment of Harry L. Leider, MD, MBA as its new Chief Executive Officer (CEO). Dr. Leider has a distinguished background as a highly innovative healthcare executive and entrepreneur with extensive experience serving in C-suite roles - in both publicly-held and early-stage companies.

Dr. Leider's exceptional career spans over 25 years of success advancing breakthroughs in patient care across multiple sectors of the healthcare industry. Prior to joining Organicell, Dr. Leider served as the Chief Medical Officer and Executive Vice President of Gelesis, a biotech company specializing in therapies for obesity. Under his leadership, the company successfully completed the process to gain FDA approval for their lead product (Plenity^®) and then successfully commercialized Plenity^® via a unique direct-to-consumer model supported by a national telemedicine program. Furthermore, he played a key role as part of a small leadership team that led the company through its initial public offering on the New York Stock Exchange (NYSE).

Previously, Dr. Leider served as Chief Medical Officer and Group Vice President for Walgreens Boots Alliance. His contributions were instrumental in shaping the company's strategic direction for its healthcare initiatives. He provided executive leadership for all clinical programs, quality assessment activities, health outcomes research, and health analytics projects across this Fortune 50 company. Prior to Walgreens, he served as Chief Medical Officer and Executive Vice President at Ameritox - a specialty laboratory company that enabled physicians to more safely treat patients suffering with chronic pain. Dr. Leider has also participated on the Board of Directors of Alivio Therapeutics, TytoCare, and Mobile Help.

Over his career, Dr. Leider served on the faculty of the Johns Hopkins Carey School of Business and Harvard Medical School, and has published over 25 articles and chapters related to patient care and organizational leadership in peer-reviewed journals and books. He also was a core faculty member of the American Association of Physician Leadership for over 20 years and has published five patents in the field of laboratory medicine.